Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multimodal LAI with vs without PCI in TKA
NCT02860949Phase 2Completed
- Sponsor
- Thammasat University
- Start
- Apr 2014
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bupivacaine, morphine, ketorolac, epinephrine in osteoarthritis (OA), sponsored by Thammasat University. Started Apr 2014; status: completed.
02
Drugs
bupivacainemorphineketorolacepinephrine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02860949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02860949.